logo
#

Latest news with #physicians

Concierge Medicine Market Size Worth USD 39.02 Billion by 2034 Amid Demand for Personalized Healthcare
Concierge Medicine Market Size Worth USD 39.02 Billion by 2034 Amid Demand for Personalized Healthcare

Yahoo

time2 days ago

  • Business
  • Yahoo

Concierge Medicine Market Size Worth USD 39.02 Billion by 2034 Amid Demand for Personalized Healthcare

The global concierge medicine market size is expected to be worth USD 39.02 billion by 2034, up from USD 21.77 billion in 2025 and is projected to register an impressive CAGR of 6.7% during the forecast period from 2025 to 2034. This growth is primarily driven by the rising demand for personalized and preventive healthcare services, as patients increasingly seek direct access to physicians, longer consultation times, and improved care continuity. Ottawa, July 28, 2025 (GLOBE NEWSWIRE) -- According to Precedence Research, the concierge medicine market size has been accounted for USD 21.77 billion in 2025 and is predicted to rise from USD 23.23 billion in 2026 to approximately USD 39.02 billion by 2034. During 2025 to 2034, the market is expected to grow at a solid CAGR of 6.70%. The increased need for concierge medicine is driven by the emphasis on personalized and preventive care and improved patient satisfaction. Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for Before You Buy – Get the Sample Report@ Quick Insights: Concierge Medicine Market Key Takeaways In terms of revenue, the global concierge medicine market was valued at USD 20.40 billion in 2024. It is anticipated to reach over USD 39.02 billion by 2034. The market is poised to grow at a notable compound annual growth rate (CAGR) of 6.70% from 2025 to 2034. North America accounted for the largest market share of 43% in 2024. Asia Pacific is expected to grow at the fastest CAGR between 2025 and 2034. By application, the primary care contributed the highest market share of 27.3% in 2024. By application, the pediatrics segment is expected to grow at a strong CAGR from 2025 to 2034. By ownership, the group segment held the major market share of 64% in 2024. By ownership, the independent segment is expected to grow at the fastest CAGR during the forecast period. Concierge Medicine Market Overview and Industry Potential What is Concierge Medicine? Concierge medicine refers to the association between patients and physicians through which special care is provided to patients who reserve high-end premium packages in advance. It involves payments in the form of monthly or annual fixed fees for same-day appointments or 24/7 physician availability. This package encompasses pediatricians, urgent care clinics, house calls of the doctor, medical specialists, or primary care physicians. The healthcare professionals involved in these packages generally set their special appointments to visit and care only for their concierge service patients. Also Read @ How Concierge Medicine Complements the Precision Medicine Revolution in the U.S. Concierge medicine is redefining the patient-provider relationship by enabling faster, more personalized care,' said Rohan Patil, Principal Consultant at Precedence Research. 'As healthcare shifts toward individualized service models, this market is poised for transformative growth. Concierge Medicine Market Major Trends: What are the Major Trends in Concierge Medicine and Healthcare Membership? Integration of Telehealth: There is an integration of telehealth into concierge practices which is coupled with technological advancements and acceptance of virtual visits. It has resulted in increased utilization of resources and adherence to quality measures like accreditation. Telehealth assists in treating injuries, illness, and promotes longevity. Quality Care: For this purpose, several healthcare professionals such as nurse practitioners, membership models, concierge physician specialties, etc. are involved in concierge medicine practices. They impact access, the levels of quality of care, and cost. These practices ensure a balanced quality of care for patients. Discover the Complete Findings@ Concierge Medicine Market Growth Factors Why Should Patients Choose Concierge Services? No more Hurried Visits: People do not feel that their medical visits are going to be rushed due to the high workload of healthcare workers. Physicians stick to a strict appointment timeline to see every patient who needs medical care. Direct Access to Healthcare Provider: Patients undergoing medical care through concierge service packages experience good availability and accessibility of medical providers. The patients are always a priority of their healthcare professionals. What is the Role of the Cutting-edge Artificial Intelligence in the Concierge Medicine Market? Artificial Intelligence powered tools assist in image recognition, where they can analyze medical images with high precision. They can also identify abnormalities in the human body through medical images that cannot be seen through the human eye. These approaches are very useful in the dermatology and radiology fields. AI is not only enhancing image diagnostics but also powering personalized treatment planning, remote patient monitoring, and intelligent scheduling. Concierge platforms are leveraging AI chatbots for 24/7 communication, predictive analytics for early disease detection, and tailored wellness plans based on biometric data. MORE FOR YOU: ➢ AI in Healthcare Market Size, AI-Powered Diagnostics & Enhancing Accuracy ➢ How AI Is Reshaping Medical Imaging: A $14.46 Billion Market Opportunity by 2034 ➢ Medical Imaging on the Rise: Market Growth, Key Segments & Regional Outlook Opportunities in the Concierge Medicine Market In December 2024, Sollis Health announced the investment of $33 million in series B funding to boost product innovation, member experience, and expansion across the nation. (Source: In November 2024, Bajaj Finserv Health announced the investment of INR 1,000 Crore in technology and services to launch 'Health Saathi' concierge. (Source: Concierge Medicine Market Challenges and Limitations: What are the Key Problems associated with Concierge Medicine? Out-of-Pocket Costs: Personalized healthcare is related to its own price tag and patients feel a prohibitive membership fee. These out-of-pocket services may not be included under the prescriptions, concierge umbrella-like specialist visits, and hospital stays. Challenging Insurance Billing: Patients can face issues regarding transparency in healthcare services and insurance billing. This process involves endless phone calls, policies, and vague responses that can leave patients more baffled than informed. Out-of-pocket membership fees typically range between USD 1,500 to USD 5,000 annually in the U.S., depending on the level of service. This pricing model can limit access for middle-income populations and may not be covered by traditional insurance models. Also Read@ Why Hospitals Are Outsourcing Billing: Insights Into the USD 54 B Market Boom Scope of Concierge Medicine Market Report Attributes Statistics Market Size in 2024 USD 20.40 Billion Market Size in 2025 USD 21.77 Billion Market Size by 2034 USD 39.02 Billion Growth Rate (2025–2034) CAGR of 6.70% U.S. Market Size in 2025 USD 6.55 Billion U.S. Market Size in 2034 USD 1.97 Billion U.S. Market Growth Rate (2025–2034) CAGR of 6.88% Base Year 2024 Forecast Period 2025 to 2034 Dominant Market North America – due to higher adoption of retainer-based healthcare models Fastest Growing Region Asia Pacific – driven by rising demand for premium healthcare services Benefits for Buyers • Understand regional trends• Compare revenue share• Identify growth pockets and investment zones Segments Covered Application, Ownership, and Regions Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa Top Companies Covered PartnerMD, Crossover Health, MDVIP, CONCIERGE CONSULTANTS & CARDIOLOGY, Signature MD, Peninsula Doctor, Winstead PC, Castle Connolly Private Health Partners, Specialdocs Consultants, LLC., Priority Physicians, Inc. Real‑World Case Studies: How Concierge Medicine Is Reshaping Healthcare 1) Human Longevity Clinic — Silicon Valley (2025) Case Summary:In early 2025, the Human Longevity Clinic in South San Francisco gained attention for offering ultra-premium, AI-integrated longevity plans priced between USD 8,000 and 19,000 per year. Patients undergo advanced diagnostics, including full-body MRIs, genome sequencing, cardiac scans, and blood panels, generating over 150GB of health data per client. Outcome Highlights: Detected early-stage aneurysms and tumors in asymptomatic patients. Personalized plans improved long-term prognosis through lifestyle interventions. AI tools assisted with anomaly detection, enhancing care quality beyond traditional diagnostics. Why It Matters:This example illustrates the growing appeal of preventive concierge models, blending precision diagnostics and tech-driven personalization. It aligns perfectly with your report's insights on AI integration, growing demand for preventive care, and willingness to pay for high-touch services. 2) Dr. Khalid Saeed's House Call Concierge Model — Tampa Bay, Florida (2023–2024) Case Summary:Dr. Khalid Saeed launched a concierge house-call practice offering personalized in-home and virtual care with monthly fees between USD 150–800, depending on patient complexity. His business model is insurance-free, catering to ~250 patients with 24/7 access. Outcome Highlights: Patients report dramatically reduced stress and stronger physician relationships. The practice operates profitably with minimal administrative burden. A blend of telehealth and in-person visits enables efficient chronic care management. Why It Matters:This model reflects the group and independent ownership trends cited in your report, showing how small-scale practices can thrive by offering personal, direct access to healthcare. It also supports your forecast for independent practices growing at the fastest CAGR during 2025–2034 Set up a meeting at your convenience to get more insights instantly! Concierge Medicine Market Regional Analysis: How North America Dominated the Concierge Medicine Market in 2024? North America dominated the concierge medicine market in 2024 owing to the increased demand for personalized care and chronic disease prevalence. This region is making efforts to accomplish its ambitious vision across infrastructure, health, science, tourism, technology, entertainment, and renewable energy. The U.S. makes partnerships with tech companies and investors to become a leader in next-generation technologies and digital infrastructure. Also Read@ Global Medical Tourism: How a USD 43.5 B Industry in 2025 Is Transforming Healthcare Trave How Big is the U.S. Concierge Medicine Industry? According to Precedence Research, the U.S. concierge medicine market size was valued at USD 6.14 billion in 2024 and is projected to reach USD 11.97 billion by 2034, growing at a CAGR of 6.88% from 2025 to 2034. Consumers are driving growth in this market by seeking personalized care, including direct physician access, longer consultations, and same- or next-day appointments, enabled by membership-based, low-patient-load models. U.S. Concierge Medicine Market – Key Takeaways By Application: The "Others" segment accounted for the largest market share in 2024, leading the U.S. concierge medicine landscape. Primary Care Segment: Expected to remain the second-largest application segment throughout the forecast period, demonstrating consistent demand and adoption. By Ownership: The group ownership model dominated the market in 2024, capturing the highest share among ownership types. Note: This Report is Readily Available for Immediate Delivery| Download the Sample Pages of this Report@ U.S. Concierge Medicine Market Top Companies Priority Physicians, Inc Castle Connolly Private Health Partners Partner MD Concierge Consultants and Cardiology U.S. Concierge Medicine Market Key Drivers: Physician Burnout & Shift in Practice Models: Many U.S. doctors are transitioning away from high-volume, insurance-based models to concierge practices to reduce administrative burdens and improve patient relationships. Consumer Demand for Better Access: Patients are willing to pay out-of-pocket fees (typically $1,500–$3,000/year) for longer appointments, direct communication, and same-day scheduling. Chronic Disease Prevalence: With rising cases of diabetes, obesity, and heart disease, concierge medicine allows for continuous care and lifestyle management that traditional practices often lack time for. Employer-Sponsored Concierge Care: Corporations are increasingly offering concierge medical services as a benefit to executives and high-performing employees, recognizing its value in reducing absenteeism and improving health outcomes. Japan Concierge Medicine Market Key Drivers: Aging Population & Chronic Disease Burden: With over 28% of Japan's population aged 65 and older, there is increasing demand for continuous care, home visits, and customized treatment plans, which concierge models are well-equipped to provide. Rising Interest in Preventive Health & Wellness: Japan's healthcare culture emphasizes longevity and wellness, aligning well with concierge medicine's focus on preventive screenings, lifestyle planning, and holistic care. High Expectations for Quality & Privacy: Wealthier patients and business executives in Japan are willing to pay premium fees for private, convenient, and responsive medical services, especially in metro areas like Tokyo, Osaka, and Yokohama. For instance, Tokyo-based startup 'PrimeDoc' launched a membership plan in 2024 targeting C-level executives and foreign residents, offering multilingual concierge services and AI-powered diagnostics. Corporate Adoption: Some high-end concierge services are being introduced by private hospitals and corporate health programs to cater to senior executives and foreign residents. For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@ How Asia Pacific is Moving towards Sustainable Development in 2025? Asia Pacific is expected to grow at the fastest CAGR in the concierge medicine market during the forecast period due to rising disposable income and growing healthcare awareness. The Economic and Social Commission for Asia and the Pacific and the regional platform make efforts to empower, inform, and support Asian Pacific countries to achieve sustainable development goals. These countries include less developed countries, small island developing states, and landlocked developing countries. In February 2025, the Asia-Pacific Forum on Sustainable Development (APFSD) was organized to advance sustainable, science-based, evidence-based, and inclusive solutions for good health, well-being, gender equality, economic growth, and decent work. Concierge Medicine Market Segmentation Analysis: Application Analysis How Primary Care Segment Dominated the Concierge Medicine Market in 2024? The primary care segment dominated the concierge medicine market in 2024 owing to increased accessibility and convenience. Consumers are paying attention to personalized and preventive care, which also improves management of chronic conditions. One of the key drivers of this segment's growth is the rising consumer focus on preventive and proactive health management. Patients are no longer satisfied with reactive, episodic care; instead, they are seeking ongoing monitoring, wellness planning, and chronic disease management, all of which are core offerings in concierge primary care models. This approach is especially valuable for patients with conditions such as diabetes, hypertension, and cardiovascular issues, where continuity of care and close monitoring significantly impact outcomes. The pediatrics segment is expected to grow at the fastest CAGR in the concierge medicine market during the forecast period due to proactive healthcare management. Pediatric care is available in the form of at-home convenience, personalized care, and healthcare attention. Also Read@ Population Health Management Market Set to Reach USD 625.9 B by 2034 – What's Fueling the Surge Ownership Analysis What made Group the Dominant Segment in the Concierge Medicine Market in 2024? The group segment dominated the concierge medicine market in 2024 owing to enhanced patient relationships and reduced administrative burden. Group ownership allows financial stability, predictability, scalability, and resource sharing. The independent segment is expected to grow at the fastest CAGR in the concierge medicine market during the forecast period due to work-life balance and improved patient retention. It causes reduced reliance on insurance reimbursements and streamlined operations. Related Topics You May Find Useful: ➢ Artificial Intelligence (AI) In Precision Medicine Market: The global AI in precision medicine market size was accounted for USD 2.32 billion in 2024 and is anticipated to reach around USD 49.49 billion by 2034, growing at a CAGR of 35.80% from 2025 to 2034. ➢ Regenerative Medicine Market: The global regenerative medicine market size accounted for USD 35.80 billion in 2024 and is predicted to increase from USD 43.80 billion in 2025 to approximately USD 212.80 billion by 2034, expanding at a CAGR of 19.20% from 2025 to 2034. ➢ Complementary and Alternative Medicine Market: The global complementary and alternative medicine market size was valued at USD 154.69 billion in 2024 and is expected to reach over USD 1282.70 billion by 2034, poised to grow at a CAGR of 23.56% from 2025 to 2034. ➢ eHealth 2.0 Market: The global eHealth 2.0 market size accounted for USD 347.54 billion in 2024 and is predicted to increase from USD 381.36 billion in 2025 to approximately USD 879.55 billion by 2034, expanding at a CAGR of 9.73% from 2025 to 2034. ➢ Personalized Medicine Market: The global personalized medicine market was calculated at USD 614.22 billion in 2024 and is predicted to increase from USD 654.46 billion in 2025 to approximately USD 1,315.43 billion by 2034, expanding at a CAGR of 8.10% from 2025 to 2034. Concierge Medicine Market Leading Companies MDVIP SignatureMD Concierge Choice Physicians Crossover Health Specialdocs Consultants Castle Connolly Private Health Partners, LLC Peninsula Doctor Concierge Medicine HealthAssure Private Limited One Medical Priority Physicians of Carmel, Inc. UC San Diego Health What is Going Around the Globe? In September 2024, WhiteGlove announced the launch of AI-Enabled Medical Concierge to assist immigrants in caring for family living abroad. (Source: In October 2024, Sollis Health announced the launch of its first family membership that can recognize the needs of parents for an integrated emergency and everyday care company. (Source: Concierge Medicine Market Segments Covered in the Report By Application Primary Care Cardiology Pediatrics Psychiatry Internal Care Others By Ownership Independent Group By Region North America U.S. Canada Mexico Asia Pacific China Singapore Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa South Africa UAE Saudi Arabia Kuwait Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as Immediate Delivery Available | Buy This Premium Research Report@ You can place an order or ask any questions, please feel free to contact at sales@ | +1 804 441 9344 Stay Ahead with Precedence Research Subscriptions Unlock exclusive access to powerful market intelligence, real-time data, and forward-looking insights, tailored to your business. From trend tracking to competitive analysis, our subscription plans keep you informed, agile, and ahead of the curve. Browse Our Subscription Plans@ About Us Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. Web: Our Trusted Data Partners: Towards Healthcare | Towards Packaging | Towards Automotive | Towards Chem and Materials | Towards FnB | Towards Consumer Goods | Statifacts | Towards EV Solutions | Towards Dental | Nova One Advisor Get Recent News: For the Latest Update Follow Us: LinkedIn | Facebook | TwitterSign in to access your portfolio

Most GLP-1 Prescriptions Miss the Mark: Are Yours?
Most GLP-1 Prescriptions Miss the Mark: Are Yours?

Medscape

time2 days ago

  • Health
  • Medscape

Most GLP-1 Prescriptions Miss the Mark: Are Yours?

GLP-1 receptor agonists, including semaglutide, are now widely used for weight loss, offering substantial weight reduction, improved metabolic health, and reduced cardiovascular risk. However, effective treatment involves more than simply prescribing drugs, and ongoing clinical oversight is crucial. Based on recommendations published in JAMA Internal Medicine , the following five tips can help physicians avoid common pitfalls and deliver optimal patient care. Track Weight GLP-1 receptor agonists typically result in 15%-21% weight loss, depending on the drug and individual response. However, weight loss alone does not define treatment success. A comprehensive clinical assessment that incorporates both quantitative and qualitative factors is essential. Weight should be monitored monthly during the initial phase of treatment, particularly during dose titration. Once the dose is stabilized, quarterly follow-up is usually sufficient. If the weight loss remains below 5% after 12-16 weeks, this may signal an inadequate response. In such cases, clinicians should assess adherence, consider dose adjustments, or evaluate the need to switch to another GLP-1 receptor agonist. Marked weight loss should be evaluated clinically and not just numerically. Red flags include a BMI below 18.5, calorie intake under 800 kcal/d, hormonal disturbances such as amenorrhea or reduced libido, signs of protein deficiency, and psychological symptoms. In such cases, secondary causes should be investigated, dose reduction should be considered, and referral to clinical nutrition or psychosomatic medicine may be warranted. Preserve Muscle Physicians should be mindful of lean body mass loss when treating patients with GLP-1 receptor agonists. Research indicates that up to 40% of the total weight loss during therapy may be attributed to muscle loss, which is a clinically relevant concern, particularly in older adults or those with limited physical function. Targeted prevention of muscle loss is essential and begins with adequate protein intake. At least 1.0-1.5 g/kg body weight per day is recommended, with even higher amounts (> 1.5 g/kg) advised for older adults or patients who have undergone bariatric surgery. If appetite is significantly reduced, protein-rich supplements, such as shakes containing at least 20 g of protein per serving, can be a practical option. Physicians should also recommend structured and individualized physical activities. In addition to approximately 150 minutes of moderate endurance exercise per week, such as brisk walking or cycling, strength training should be incorporated two to three times weekly. This approach can limit muscle loss by up to 95%, according to studies, while also improving metabolic health. Many patients report noticeable gains in energy, mobility, and quality of life. Monitor Micronutrients GLP-1 receptor agonists reduce food intake and slow gastric emptying, which may worsen preexisting micronutrient deficiencies. Individuals with obesity frequently have deficiencies in vitamin D, vitamin B12, folate, iron, zinc, calcium, and magnesium prior to treatment. Therefore, targeted laboratory testing is recommended before starting treatment or at the latest when clinical signs of deficiency appear. High-risk patients should receive early referrals for professional dietary counselling, such as from a registered dietitian. If direct access is unavailable, the validated screening tool, the Rapid Eating Assessment for Participants — Shortened Version, offers an efficient and time-saving alternative for initial screening. Based on the test results, clinicians can recommend an individualized approach focusing on a nutrient-rich diet rather than calorie counting. Targeted supplementation may be appropriate in many cases. Manage Side Effects Nausea, bloating, reflux, and constipation are among the most common side effects of GLP-1 receptor agonists, particularly during treatment initiation or when the dose is increased. Patient education and symptom-specific interventions can significantly improve the tolerability of these treatments. For nausea: Advise small, low-fat meals; avoid fried foods; and consider ginger tea for symptom relief. For constipation: Encourage fluid intake of more than 2-3 L/d, a high-fiber diet such as oatmeal and vegetables with their peel, and short-term use of osmotic laxatives, if needed. For reflux: Recommend smaller meals, maintain an upright position after eating, and avoid spicy or caffeinated beverages. Prevent Relapse Many patients regain weight after discontinuing semaglutide or other GLP-1 receptor agonists, with studies showing an average weight regain of 7%-12% within a year. This risk highlights that obesity is not a temporary condition but a chronic disease that should be managed accordingly. Setting realistic expectations and developing long-term strategies from the start of treatment are essential. A structured discontinuation plan, such as gradual dose reduction with close follow-up, can help prevent the risk for relapse. Lifestyle interventions should also be consistently maintained, including a balanced, nutrient-rich diet, regular physical activity, and psychological support when needed. If the weight gain exceeds 5%, further treatment with GLP-1 receptor agonists may be advisable.

Claims Data Fail to Accurately Identify MI Types
Claims Data Fail to Accurately Identify MI Types

Medscape

time2 days ago

  • Health
  • Medscape

Claims Data Fail to Accurately Identify MI Types

TOPLINE: Clinical auditing reveals significant misclassification in administrative codes for myocardial infarction (MI), with only 39% of type 1 (T1MI) codes and 72% of type 2 (T2MI) codes for the condition accurately reflecting the true diagnosis, researchers found. Nearly half of patients coded for T1MI had T2MI, whereas 26% of T2MI codes represented myocardial injury. METHODOLOGY: Researchers identified 350 randomly sampled patients with T1MI codes and 350 patients with T2MI codes during inpatient encounters using the International Statistical Classification of Diseases and Related Health Problems-10th Revision. The analysis included patients aged 65 years and older from October 1, 2017, to May 9, 2024, within eight hospitals in the Mass General Brigham system. Using the 4th Universal Definition of MI, the researchers reviewed the clinical encounters to assess evidence of plaque erosion or thrombus vs oxygen demand-supply imbalance. A second physician review was conducted for 146 challenging and 146 nonchallenging cases. TAKEAWAY: Among the 350 patients coded as having had T1MI, clinical adjudication revealed 138 (39%) as correctly diagnosed; 159 (45%) in fact had T2MI, and 35 (10%) had myocardial injury. Of the 350 patients coded as having had T2MI, 251 (72%) were confirmed, four (1%) were found to have T1MI, and 91 (26%) had myocardial injury. A second physician review demonstrated a high degree of agreement with the initial review, with a 94% agreement in nonchallenging cases and 86% in challenging cases. Hospitals equipped with vs without cardiac catheterization laboratories showed significantly lower misclassification rates (43% vs 58%; P = .0298). IN PRACTICE: 'Among individuals assigned a T1MI claims code, nearly one half have T2MI and many others have myocardial injury; fewer than one half have true T1MI,' the researchers reported. 'Our results also confirm and extend previous work showing that among those with T2MI codes, slightly more than one half have true T2MI, with most of the misclassification related to myocardial injury rather than T1MI. This has critically important implications for epidemiology and public policy' related to acute myocardial infarction. SOURCE: The study was led by Andrea Martinez, MD, of the Department of Medicine at Massachusetts General Hospital, Boston. It was published online on July 21 in Journal of the American College of Cardiology. LIMITATIONS: The results may not be generalized to other hospital systems and countries, where patterns of misclassification might differ. The researchers noted external validity assessment across multiple healthcare systems and in countries that have already introduced International Classification of Diseases-11th revision coding would be beneficial. While patterns of misclassification might have changed over time, the analysis was intentionally restricted to the period when codes for both T1MI and T2MI were available. DISCLOSURES: The study received support through a grant to Jason Wasfy from the Massachusetts General Hospital Executive Committee on Research. Individual authors reported receiving other grants and support, including grants from industry. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Bangladesh Chief Adviser thanks foreign medical teams, including India for treating plane crash victims
Bangladesh Chief Adviser thanks foreign medical teams, including India for treating plane crash victims

Times of Oman

time3 days ago

  • Health
  • Times of Oman

Bangladesh Chief Adviser thanks foreign medical teams, including India for treating plane crash victims

Dhaka: A delegation of 21 physicians and nurses from Singapore, China, and India met with Bangladesh's Chief Adviser Professor Muhammad Yunus on Sunday at the State Guest House Jamuna. The international medical teams are currently in Dhaka to provide specialised healthcare services to victims of the recent plane crash at Milestone School and College. During the meeting, Professor Muhammad Yunus expressed his heartfelt gratitude for the rapid response and medical support extended by the healthcare professionals. He commended their dedication and solidarity at a time of national crisis and emphasised the importance of international cooperation in emergency healthcare. "These teams have come not just with their skills, but with their hearts," said Professor Yunus. "Their presence reaffirms our shared humanity and the value of global partnerships in times of tragedy," he added. The medical teams have been working tirelessly alongside local healthcare professionals to ensure critical treatment and trauma care for the injured, many of whom are young children. The Chief Adviser also acknowledged the swift diplomatic coordination that enabled the teams to arrive and begin their work without delay. He assured the visiting professionals of the government's full support in facilitating their mission. The Chief Adviser also urged the physicians to maintain long-term connections with Bangladesh, even virtually, for institutional collaboration, medical education exchange, and sustained engagement in capacity building and innovation in the healthcare sector. He emphasised that such partnerships could lay the foundation for lasting cooperation in public health and emergency preparedness. Health Adviser Nurjahan Begum thanked the physicians and nurses for extending their hand during this difficult time. Professor Sayedur Rahman, special assistant to the Chief Adviser for the Ministry of Health, said that many lives were saved as the foreign physicians rushed immediately. At the meeting, Prof Dr Md. Nasir Uddin, Director, National Institute of Burn & Plastic Surgery (NIBPS), said that it was proven again that doctors are without borders. Ten members from Singapore, eight from China, and four from India attended the meeting. Among others, the Chinese Ambassador to Dhaka, Yao Wen, and the Singapore Head of Mission in Dhaka were also present at the meeting. On July 21, 2025, a Bangladesh Air Force training aircraft, specifically a Chinese-origin F-7 BGI fighter jet, crashed into the Milestone School and College campus in Dhaka's Uttara neighbourhood. The crash resulted in the deaths of at least 27 people and injured over 170 others, mostly students. Bangladesh's interim government declared a national day of mourning on July 22, with flags flown at half-mast in all government offices and educational institutions.

Could Direct Primary Care's Popularity Be on the Rise?
Could Direct Primary Care's Popularity Be on the Rise?

Medscape

time5 days ago

  • Health
  • Medscape

Could Direct Primary Care's Popularity Be on the Rise?

Recent budget reconciliation legislation allows health savings accounts (HSAs) to cover Direct Primary Care (DPC) services. Here are the pros and cons. DPC Basics Unlike the setup of a traditional medical practice, DPCs provide services by charging membership fees. Historically, if an individual chose to be a DCP patient, they would pay membership fees on their own, with membership skewing towards those with the financial means to join. DPC Upsides for Providers and Patients DCP patient loads are smaller, allowing more timely, personalized care for patients. Those factors, along with unlimited access to their provider and the coverage of routine medical needs, are big upsides for members. A DCP practice enables providers to move away from the challenges associated with traditional healthcare models. DCP and HSA The new budget reconciliation law, in accordance with IRS guidelines, recognizes DCP memberships as a medical expense that HSA funds can pay for. Will DCP Become More Popular? Individuals previously unable to afford DPC memberships may now find value in utilizing their HSA funds for a more customized healthcare experience, especially if dissatisfied with their current care. Effects on the Traditional Healthcare System Shifts toward DCPs could increase the expenses involved in traditional practice, resulting in higher financial burdens for remaining patients who do not have an HSA, and therefore do not have the option to switch. The new law may also entice physicians to leave their current situation, which would leave practices with fewer providers. Bottom line: Now that HSA funds can be used for DCP memberships, a shift away from traditional practices is possible. The impact could be negative for some and beneficial for others.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store